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Paper Alert
Chosen by Robert Liddington1 and Christin Frederick2
A selection of interesting papers that were published in
the month before our press date in major journals most
likely to report significant results in structural biology.
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Structure 1998, Vol 6 No 1:117–119
n Tertiary and quaternary structures of 0.19 a-amylase
inhibitor from wheat kernel determined by X-ray analysis
at 2.06 Å resolution. Yutaka Oda, Takateru Matsunaga,
Keiichi Fukuyama, Toshiyuki Miyazaki and Toshihisa
Morimoto (1997). Biochemistry 36, 13503–13511.
Protein inhibitors of α-amylase are widely found in prokaryotic
and eukaryotic cells and have inhibitory activity on α-amylases,
the enzymes responsible for cleavage of α(1–4) glucoside
bonds present in glycogen and starch. The crystal structure of
0.19 α-amylase inhibitor (0.19 AI) from wheat kernel has been
determined. The asymmetric unit contains four molecules of
0.19 AI, each comprised of 124 amino acid residues. Each
subunit has four major α helices and one one-turn helix which
are arranged in the up-and-down manner. All ten cysteine
residues in 0.19 AI form disulfide bonds.
4 November 1997, Biochemistry
n Crystal structure of the Escherichia coli peptide
deformylase. Michael K Chan, Weimin Ging, PT Ravi
Rajagopalan, Bing Hao, Chris M Tsai and Dehua Pei
(1997). Biochemistry 36, 13904–13909.
The authors report the 2.9 Å X-ray structure of the zinc-
containing Escherichia coli peptide deformylase, the enzyme
that catalyzes the removal of the N-terminal formyl group for
the majority of bacterial proteins. Although the primary
sequence, tertiary structure and use of coordinated cysteine
suggest that E. coli deformylase belongs to a new subfamily of
metalloproteases, the environment around the metal appears to
have strong geometric similarity to the active sites of the
thermolysin family, suggesting possible similarity in their
hydrolytic mechanisms.
11 November 1997, Biochemistry
n The structure of ClpP at 2.3 Å resolution suggests a
model for ATP-dependent proteolysis. Jimin Wang, James
A Hartling and John Flanagan (1997). Cell 91, 447–456.
The authors have determined the crystal structure of the
proteolytic component of the caseinolytic Clp protease (ClpP)
from Escherichia coli at 2.3 Å resolution using an ab initio
phasing procedure that exploits the internal 14-fold symmetry
of the oligomer. The structure of a ClpP monomer has a
distinct fold that defines a fifth structural family of serine
proteases but a conserved catalytic apparatus. The active
protease resembles a hollow, solid-walled, cylinder composed
of two sevenfold symmetric rings stacked back-to-back.
14 November 1997, Cell
n Crystal structure at 1.7 Å resolution of VEGF in complex
with domain 2 of the Flt-1 receptor. Christian Wiesmann,
Germaine Fuh, Hans W Christinger, Charles Eigenbrot,
James A Wells and Abraham M de Vos (1997). Cell 91,
695–704.
Vascular endothelial growth factor (VEGF) is a homodimeric
hormone that induces proliferation of endothelial cells through
binding to the kinase domain receptor and the Fms-like
tyrosine kinase receptor (Flt-1), the extracellular portions of
which consist of seven immunoglobulin domains. The crystal
structure of the complex between VEGF and the second
domain of Flt-1 shows domain 2 in a predominantly
hydrophobic interaction with the ‘poles’ of the VEGF dimer.
On the basis of this structure and mutational data, the authors
present a model of VEGF bound to the first domains of Flt-1.
28 November 1997, Cell
n Metals, motifs, and recognition in the crystal structure of
a 5S rRNA domain. Carl C Correll, Betty Freeborn, Peter B
Moore and Thomas A Steitz (1997). Cell 91, 705–712.
Two new RNA structures portray how non-Watson–Crick base
pairs and metal ions can produce a unique RNA shape suitable
for recognition by proteins. The crystal structures of a 62
nucleotide domain of Escherichia coli 5S ribosomal RNA and a
duplex dodecamer encompassing an internal loop E have been
determined at 3.0 and 1.5 Å, respectively. This loop E region is
distorted by three ‘cross-strand purine stacks’ and three novel,
water-mediated, noncanonical base pairs and stabilized by a
four-metal ion zipper.
28 November 1997, Cell
n The crystal structure of the human DNA repair
endonuclease HAP1 suggests the recognition of
extra-helical deoxyribose at DNA abasic sites.
Michael A Gorman, Solange Morera, Dominic G Rothwell,
Eric de La Fortelle, Clifford D Mol, John A Tainer, Ian D
Hickson and Paul S Freemont (1997). EMBO J. 16,
6548–6558.
The paper describes the crystal structure of the major human
apurinic/apyrimidinic endonuclease. The enzyme consists of
n See the Minireview article by Sudip S Parikh, Clifford D Mol and John A Tainer in the 15 December issue of Structure (volume
5:1543–1550).
two symmetrically related domains of similar topology and has
significant structural similarity to bovine DNase I. The
structure suggests a model for base recognition involving an
extra-helical conformation, rather than a ‘flipped-out’ base.
3 November 1997, The EMBO Journal
n Solution structure of the transforming growth factor
b-binding protein-like module, a domain associated with
matrix fibrils. Xuemei Yuan, A Kristina Downing, Vroni Knott
and Penny A Handford (1997). EMBO J. 16, 6659–6666.
The solution structure of a transforming growth factor β
(TGF-β)-binding protein-like (TB) domain, from human
fibrillin-1, reveals a novel fold with six antiparallel β strands,
two α helices and four disulfide bonds. Implications for the
specificity of TB domain interactions are discussed.
17 November 1997, The EMBO Journal
n Substrate-assisted catalysis unifies two families of
chitinolytic enzymes. Ivo Tews, Anke C Terwisscha van
Scheltinga, Anastassis Perrakis, Keith S Wilson and Bauke
W Djikstra (1997). J. Am. Chem. Soc. 119, 7954–7959.
X-ray structures of three different chitinolytic enzymes
complexed with substrates or inhibitors identify a retaining
mechanism involving a protein acid and the carbonyl oxygen
atom of the substrate’s C2 N-acetyl group as the nucleophile.
These studies demonstrate the distortion of the sugar ring
toward a sofa conformation, long postulated as being close to
that of the transition state in glycosyl hydrolysis.
November 1997, The Journal of the American Chemical
Society
n Crystal structure of the I domain from integrin a2b1.
Jonas Emsley, Sandra L King, Jeffrey M Bergelson and
Robert C Liddington (1997). J. Biol. Chem 272,
28512–28517.
This paper describes the crystal structure of the I domain from
integrin α2β1, a cell surface adhesion receptor for collagen and
the human pathogen echovirus-1. Comparison with the
leukocyte integrin I domains reveals a new helix (the C-helix)
protruding from the metal ion dependent adhesion site face of
the domain, which creates a groove centered on the magnesium
ion. Models of collagen and echovirus binding are proposed.
7 November 1997, The Journal of Biological Chemistry
n Structure of the fifth EGF-like domain of
thrombomodulin: an EGF-like domain with a novel
disulfide-bonding pattern. Benedetta A Sampoli Benitez,
Michael J Hunter, David P Meininger and Elizabeth A
Komives (1997). J. Mol. Biol. 273, 913–926.
The solution structure of the fifth EGF-like domain of
thrombomodulin (TMEGF5) has been determined by NMR
spectroscopy. The structure differs in several ways from the
classic EGF fold, including a lack of the central β sheet and a
different disulfide-bonding pattern. Evidence for a thrombin-
binding surface is presented.
7 November 1997, The Journal of Molecular Biology
n Crystal structure of the protein drug urate
oxidase–inhibitor complex at 2.05 Å resolution.
Nathalie Colloc'h Mohamed El Hajji, Bernard Bachet,
Guillaume L'Hermite, Marc Schiltz, Thierry Prange,
Bertrand Castro and Jean Paul Mornon. (1997). Nat.
Struct. Biol. 4, 947–952.
The gene coding for urate oxidase, an enzyme that catalyzes
the oxidation of uric acid to allantoin, is inactivated in humans.
Consequently, urate oxidase is used as a protein drug to
overcome severe disorders induced by uric acid accumulation.
The structure of the active homotetrameric enzyme reveals the
existence of a small architectural domain, the T-fold (for
tunnelling-fold) domain. It assembles to form a perfect unusual
dimeric α8β16 barrel.
November 1997, Nature Structural Biology
n Structure of the profilin–poly-L-proline complex
involved in morphogenesis and cytoskeletal regulation.
Nicole M Mahoney, Paul A Janmey and Steven C Almo
(1997). Nat. Struct. Biol 4, 953–960.
Profilin, a ubiquitous low molecular weight actin-binding
protein, regulates the formation of F-actin structures in vivo
and is localized to specific cellular regions through interaction
with proline-rich sequences. The authors report the 2.2 Å
X-ray structure of the complex between human platelet
profilin (HPP) and a decamer of L-proline (L-Pro10). The
L-Pro10 peptide adopts a left-handed type II poly-L-proline
helix (PPII) and binds to a highly conserved patch of aromatic
amino acids on the surface of profilin.
November 1997, Nature Structural Biology
n Crystal structure of truncated human apolipoprotein A-I
suggests a lipid-bound conformation. David W Borhani,
Danise P Rogers, Jeffrey A Engler and Christie G
Brouillette (1997). Proc. Natl. Acad. Sci. USA 94,
12291–12296.
The structure of truncated human apolipoprotein A-I (apo
A-I), the major protein component of high density lipoprotein,
has been determined at 4 Å resolution. The molecule consists
almost entirely of a pseudo-continuous, amphipathic, α helix
that is punctuated by kinks at regularly spaced proline
residues; it adopts a shape similar to a horseshoe of dimensions
125 × 80 × 40 Å.
11 November 1997, Proceedings of the National Academy of
Science USA
n Atomic structure of a thermostable subdomain of HIV-1
gp41. Kemin Tan, Jin-huan Liu, Jia-huai Wang, Steven Shen
and Min Lu (1997). Proc. Natl. Acad. Sci. USA 94,
12303–12308.
Infection by HIV-1 involves the fusion of viral and cellular
membranes with subsequent transfer of viral genetic material
into the cell. The transmembrane subunit of the envelope
glycoprotein, gp41, promotes viral cell membrane fusion. A
thermostable subdomain of the α-helical trimeric complex
within gp41, denoted N34(L6)C28, can be formed by the N34
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and C28 peptides connected by a flexible linker in place of the
disulfide-bonded loop region. The three-dimensional structure
of N34(L6)C28 reveals that three molecules fold into a six-
stranded helical bundle.
11 November 1997, Proceedings of the National Academy of
Science USA
n Macromolecules in solution. Konstantin Pervushin,
Roland Riek, Gerhard Wider and Kurt Wüthrich (1997).
Proc. Natl. Acad. Sci. USA 94, 12366–12371.
Fast transverse relaxation of 1H, 15N and 13C by dipole–dipole
coupling (DD) and chemical shift anisotropy (CSA)
modulated by rotational molecular motions have a dominant
impact on the size limit for biomacromolecular structures that
can be studied by NMR spectroscopy in solution. Transverse
relaxation-optimized spectroscopy (TROSY) is an approach
for suppression of transverse relaxation in multidimensional
NMR experiments, which is based on constructive use of
interference between DD coupling and CSA. The TROSY
principle should benefit a variety of multidimensional solution
NMR experiments. 
11 November 1997, Proceedings of the National Academy of
Science USA
n Structural plasticity in a remodelled protein–protein
interface. Shane Atwell, Mark Ultsch, Abraham M de Vos
and James A Wells (1997). Science 278, 1125–1128.
Remodelling of the interface between human growth hormone
(hGH) and the extracellular domain of its receptor was studied
by deleting a critical tryptophan residue (at position 104) in
the receptor, creating a large cavity, and selecting a
pentamutant of hGH by phage display that fills the cavity and
largely restores binding affinity. A 2.1 Å resolution X-ray
structure of the mutant complex showed that the receptor
cavity was filled by selected hydrophobic mutations of hGH.
Large structural rearrangement occurred in the interface at
sites that were distant from the mutations. Such plasticity
suggests a means for protein–protein interfaces to adapt to
mutations as they coevolve.
7 November 1997, Science
n Amidation of bioactive peptides: the structure of
peptidylglycine a-hydroxylating monooxygenase.
Sean T Prigge, Aparna S Kolhekar, Betty A Eipper, Richard
E Mains and L Mario Amzel (1997). Science 278,
1300–1305.
Many neuropeptides and peptide hormones require amidation
at the C terminus for activity. Peptidylglycine α-amidating
monooxygenase (PAM) catalyses the amidation of these
diverse physiological regulators. The N-terminal domain of the
bifunctional PAM protein is a peptidylglycine α-hydroxylating
monooxygenase (PHM) with two coppers that cycle through
cupric and cuprous oxidation states. The anomalous signal of
the endogenous coppers was used to determine the structure
of the catalytic core of oxidised rat PHM with and without
bound peptide substrate. These structures suggest that the
PHM reaction proceeds via activation of substrate by a copper-
bound oxygen species.
14 November, Science
n Crystal structure of methyl-coenzyme M reductase: the
key enzyme of biological methane formation.
Ulrich Ermler, Wolfgang Grabarse, Seigo Shima, Marcel
Goubeaud and Rudolf K Thauer (1997). Science 278,
1457–1462.
Methyl-coenzyme M reductase (MCR), the enzyme
responsible for the microbial formation of methane, is a
300 kDa protein organized as a hexamer in an α2β2γ2
arrangement. The crystal structure of the enzyme from
Methanobacterium thermoautotrophicum, determined at 1.45 Å
resolution for the inactive enzyme state, reveals that two
molecules of the nickel porphinoid coenzyme F430 are
embedded between the subunits α, α′, β, and γ and α′, α, β′,
and γ′, forming two identical active sites. Each site is accessible
for the substrate methyl-coenzyme M through a narrow channel
locked after binding of the second substrate coenzyme B.
21 November 1997, Science
n A new triple-stranded a-helical bundle in solution: the
assembling of the cytosolic tail of MHC-associated
invariant chain. Andrea Motta, Pietro Amodeo, Paola
Fucile, Maria A Castiglione Morelli, Bjørn Bremnes and
Oddmund Bakke (1997). Structure 5, 1453–1464.
The invariant chain (Ii) is a transmembrane protein that
associates with the major histocompatibility complex class II
(MHC II) molecules in the endoplasmic reticulum. The
solution structure of the 27 amino acid cytosolic tail of Ii
reveals a new triple-stranded α-helical bundle in which the
helices, two parallel and one antiparallel, are almost coplanar.
The authors suggest that trimer formation forms part of a
mechanism that causes endosomal retention and enlarged
endosomes.
15 November 1997, Structure
n Crystal structure of ferrochelatase: the terminal
enzyme in heme biosynthesis. Salam Al-Karadaghi, Mats
Hansson, Stanislav Nikonov, Bodil Jönsson and Lars
Hederstedt (1997). Structure 5, 1501–1510.
Ferrochelatase catalyses the terminal step in heme
biosynthesis by inserting a ferrous ion into protoporphyrin IX.
The crystal structure of Bacillus subtilis ferrochelatase reveals
two similar domains each with a four-stranded parallel β sheet
flanked by α helices. Structural elements from both domains
create a cleft which is proposed to be the porphyrin and iron-
binding site.
15 November 1997, Structure
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